Month: May 2018

At the end of the day the most important thing whenever you consider any potential investment is whether or not it represents something that could potentially generate you a large return. The only other thing that really matters is how volatile or reliable this potential investment is. This is why many individuals have become incredibly interested in the new and exciting digital currencies that are known as cryptocurrencies. During the last year, many of these currencies experienced something that could only be called an incredible explosion and value. For example, bitcoin increased from under $1000 to over $19,000 in the span of only several months. Many individuals experienced incredible gains on their investment and became millionaires overnight. This is obviously drawn incredible interest from numerous investors around the world. Visit affiliatedork.com to learn more.

For this reason, Banyan Hill Publishing Company has decided to ask its leading investment advice experts what they thought of the trends in the cryptocurrency markets. One of the leading experts that have worked for Banyan Hill Publishing Company is Paul Mampilly. Paul Mampilly has experience working as a hedge fund manager and successful investor on Wall Street. After many years of being a successful investor on Wall Street, Paul Mampilly decided that he would rather work independently and produce investment advice that could help everyday Americans.

Paul Mampilly stated that he believes the recent trends in the cryptocurrency market show several signs that indicate it could be in an economic bubble. Paul Mampilly has experience investing in economic bubbles as he was an investor during the late 1990s in many technology companies. During this time there were many companies who had experienced an increase in their stock value of over 1000%. In the late 1990s, Paul Mampilly sold all of the stock that he had invested in these technology companies. It was not more than two years later that many of these companies experienced significant losses in the value of their stock. Paul Mampilly was able to walk away with a positive return on his investment in comparison to his friends who had held zero balances on their investment portfolios after the end of the stock market crash in the technology sector.

Louis Chenevert, a Canadian businessman, gained a lot of fame, success, and recognition during his time at United Technologies Corporation where he was the firm’s, CEO and the Chairman. Recently, Mr. Chenevert was interviewed by IdeaMensch where he recounted his life and successful business career.

Early life and before UTC

According to Louis, the star in his career shined when he joined UTC. Before UTC, he had previously worked in various companies in different capacities. For the period between 1999 and 2006, he served as the president of Pratt & Whitney. He had joined Pratt & Whitney in 1993 from General Motors where he had worked for 14 years. His time at General Motors saw him rise in the ranks to become the head of St. Therese operation center. Louis also shortly worked at Goldman Sachs at the beginning of his career. He attended Hautes Études Commerciales (HEC) where he graduated with a Bachelor of Commerce.

The star of UTC

Louis Chenevert joined UTC in March 2006 and became the firm’s President, Director and Chief Operating Officer. In April 2008, he was promoted to the CEO position and Re-elected as President. In January 2010 he was named the Chairman a position which he held until November 2014 when he retired. He says that apart from leading UTC, as the CEO he was responsible for deciding which ideas developed by his team were best suited for the development and growth of the company. According to Louis,his success at UTC was substantially supported by the great team of employees who worked under him. He says at the time, all they wanted was to meet there customers’ demands excellently.

“From the east side of America, where we chose pride over character and we can pick sides but this is us”. – The Chainsmokers (Sick Boy)

These chilling lyrics accompanied by an ambient soundscape have come from none other than America’s favorite Electronic Duo, the Chain Smokers.

Formed by Alex Pall and Andrew Taggart, the Chainsmokers are based out of New York City and since 2015 have produced multiple hit records accumulating billions of views on youtube. Although new to the scene the group has achieved decorated success winning a grammy, a mtv music award, multiple billboard awards as well as multiple #1 singles.

The Chainsmoker’s music has once been described by founding member Andrew Taggart as “blurring the lines between indie, pop music, dance music, and hip-hop.” but I would suggest that anybody interested in getting an accurate representation of what this group sounds like just listen for themselves. Over the past two to three years the group has covered extensive ground proving themselves to be genuine creatives and pushing music as a whole forward.

The Chainsmokers have reportedly decided to go in a darker direction moving forward as can be heard in theirnew song “Sick Boy” which discusses the current state of American society and the disconnect of its citizens. Although this group in particular is not known for being political, the song deals with the large divide that the political landscape in America has created and also addresses the labels people give others who they disagree with (such as “sick”).

After the release of their single “Sick Boy” which is the first track released from their newest, EP which shares the same name, many were starting to assume that when the group said it is going in a “darker” direction they meant “more socially conscious” but since the Ep has been out since the end of April 2018 it’s probably best to just let the music speak for itself, have a listen.

So I took a look at Paul Mampilly and here is my two cents with regard to “the Greatest Medical Breakthrough in History.” At first glance, it certainly appears to be a bait and switch kind of a deal. Not unlike a used snake oil sales pitch to get folks to buy into a world-shaking epiphany that would change the over arching health of human kind immediately. That is not what Paul Mampilly is about, and once I read on a little further it is apparent that there are a lot of good things that are being accomplished due to Paul Mampilly’s efforts. Learn more about Paul on Inspirery.com.

The Premise Of What Paul Mampilly is about

The notion is precision medicine, that by looking closely at a persons DNA the blueprint if you will can provide answers in developing the causes and thus the prevention of sicknesses and diseases such as Parkinson’s, Alzheimer’s, Diabetes, Arthritis, heart disease all to name just a few could potentially be wiped out by studying DNA. The place discussed was someplace called the midwestern hilltop located in Utah, called Myriad Genetics. This institution is where they carry out their practice of personalized medicine and diagnostics. They make their money by selling and processing tests that overwhelmingly check for cancer risks. The proof is in the pudding apparently for Paul Mampillys efforts have reaped increased value as stocks have increased dramatically since Myriads inception. The financial numbers speak to the worthiness of Paul Mampillys idea that potentially there is merit in his argument that the market for precision medicine will grow exponentially. It is noteworthy to mention that cancer testing once comprised 100 percent of the workload, now it is one-third of that number. To me, that is telling that Paul Mampilly is focusing on a much broader spectrum which will benefit a much larger percentage of illnesses worthy of defeating in our lifetimes. Even though Myriad was not the first time precision medicine was introduced by Paul, the first mention being FMI (Foundation Medicine) has also faired well. While FMI is less established it has done very well with a market cap of 1.5 billion. I will not get hung up on the financial numbers, my focus is strictly remaining on the accomplishments Paul Mampilly has achieved to date. Read more about Paul Mampilly at Talk Markets.

.A Great Work In Progress

It certainly appears to me that Paul Mampilly is on the right track. From reviewing the financial numbers alone he is making good progress. I for one pray that Paul continues to make positive traction with his precision medicine practices toward the overall increased health of humankind. Check: https://affiliatedork.com/banyan-hill-publishing-investment-advice

Imagine getting all of your prescription drugs from Amazon. No more trips to the pharmacy, delivery right to your doorstep and even significant savings over what you pay now.

Well, it may soon be possible because industry insiders recently revealed that Amazon is seeking pharmaceutical licenses in several states. The news sent shock waves not just through the pharmaceutical industry, but across the entire healthcare spectrum. When Amazon gets involved in any business sector – things change – dramatically.

As a possible reaction to the rumblings about Amazon, the pharmacy giant CVS may be seeking to absorb Aetna, the behemoth health insurance provider.

Why would CVS make this move? It’s not just to hedge its position against possible competition from the likes of Amazon. Health care industry watchers say that the future of companies in health care may rely on “owning customers” through all phases of their journey through the medical system, from first visit to a doctor, to getting treatment, to buying a prescription drug and finally the insurance that pays for it.

Healthcare IT entrepreneur Drew Madden is keeping a keen eye on what the likes of CVS and Amazon are doing in the healthcare realm. Madden is a managing partner of Evergreen Healthcare Partners. The company provides cutting-edge IT services to a variety of healthcare organizations across the country. The company provides implementation and advisory services across a variety of EHR platforms.

Madden, who holds a B.S.E. in industrial engineering degree from the University of Iowa College of Engineering, says a key factor is making health care more efficient, cost effective and patient focused lies in medical records management.

Drew Madden and his associates are the insider industry professionals that play integral roles in developing the nuts-and-bolts, high-tech infrastructure aspects that will bolster entities — be it Aetna, CVS or Amazon — toward achieving corporate goals as defined by their respective managements.

Madden said he is passionate about the process of “building high caliber teams” and “unique company cultures” that are anchored by trusted partnerships. Madden served as president of Nordic Consulting Partners from 2011 to 2016 before joining Evergreen Healthcare Partners.